Neuropsikofarmakologia Ikerketa Taldea

• Moreno JL, Muguruza C, Umali A, Mortillo S, Holloway T, Pilar-Cuellar F, Mocci G, Seto J, Callado LF, Neve RL, Milligan G, Sealfon SC, Lopez-Gimenez JF, Meana JJ, Benson DL, González-Maeso J.  Identification of Three Residues Essential for 5-Hydroxytryptamine 2A-Metabotropic Glutamate 2 (5-HT2A-mGlu2) Receptor Heteromerization and Its Psychoactive Behavioral Function Journal of Biological Chemistry,  2012;  287,  44301 - 44319
• Gil-Pisa I, Munarriz-Cuezva E, Ramos-Miguel A, Urigüen L, Meana JJ, García-Sevilla JA.  Regulation of munc18-1 and syntaxin-1A interactive partners in schizophrenia prefrontal cortex: down-regulation of munc18-1a isoform and 75 kDa SNARE complex after antipsychotic treatment International Journal of Neuropsychopharmacology,  2012;  15,  573 - 588
• Ortega JE, Mendiguren A, Pineda J, Meana JJ.  Regulation of central noradrenergic activity by 5-HT(3) receptors located in the locus coeruleus of the rat Neuropharmacology,  2012;  62,  2472 - 2479
• Sampedro MC, Unceta N, Gómez-Caballero A, Callado LF, Morentin B, Goicolea MA, Meana JJ, Barrio RJ.  Screening and quantification of antipsychotic drugs in human brain tissue by liquid chromatography-tandem mass spectrometry: application to postmortem diagnostics of forensic interest Forensic Science International,  2012;  219,  172 - 178
• Kurita M, Holloway T, Garcia-Bea A, Kozlenkov A, Friedman AK, Moreno JL, Heshmati M, Golden SA, Kennedy PJ, Takahashi N, Dietz DM, Mocci G, Gabilondo AM, Hanks J, Umali A, Callado LF, Gallitano AM, Neve RL, Shen L, Buxbaum JD, Han MH,. Nestler EJ, Meana JJ, Russo SJ, González-Maeso J.  HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity Nature Neuroscience,  2012;  15,  1245 - 1254
• Pérez-Santiago J, Diez-Alarcia R, Callado LF, Zhang JX, Chana G, White CH, Glatt SJ, Tsuang MT, Everall IP, Meana JJ , Woelk CH.  A combined analysis of microarray gene expression studies of the human prefrontal cortex identifies genes implicated in schizophrenia Journal of Psychiatrric Research,  2012;  46,  1464 - 1474
• Ruiz-Veguilla M, Callado LF, Ferrin M.  Neurological soft signs in patients with psychosis and cannabis abuse: a systematic review and meta-analysis of paradox Current Pharmaceutical Design,  2012;  18,  5156 - 5164
• Erdozain AM, Diez-Alarcia R, Meana JJ, Callado LF.  The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: Evidence from postmortem human brain Biochemical Pharmacology,  2012;  83(2),  260 - 268
• Ortega JE, Katner J, Davis R, Wade M, Nisenbaum L, Nomikos GG, Svensson KA, Perry KW.  Modulation of neurotransmitter release in orexin/hypocretin-2 receptor knockout mice: A microdialysis study Journal of Neuroscience Research,  2012;  90(3),  588 - 596
• Rivero G, Gabilondo AM, García-Fuster MJ, La Harpe R, García-Sevilla JA, Meana JJ.  Differential regulation of RGS proteins in the prefrontal cortex of short- and long-term human opiate abusers Neuropharmacology,  2012;  62(2),  1044 - 1051
• Alba-Delgado C, Borges G, Sánchez-Blázquez P, Ortega JE, Horrillo I, Micó JA, Meana JJ, Neto F, Berrocoso E.  The function of alpha-2-adrenoceptors in the rat locus coeruleus is preserved in the chronic constriction injury model of neuropathic pain Psychopharmacology,  2012;  221,  53 - 65
• Martisova E, Solas M, Horrillo I, Ortega JE, Meana JJ, Tordera RM, Ramírez MJ.  Long lasting effects of early-life stress on glutamatergic/GABAergic circuitry in the rat hippocampus Neuropharmacology,  2012;  62,  1944 - 1953